You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Red Sox Live



▼  5th Inning 0 outs


Celldex drug trial heartens investors

A radiologist examined breast X-rays.

Eric Gaillard/Reuters/File 2012

A radiologist examined breast X-rays.

Continue reading below

Celldex Therapeutics Inc., of Needham, said its Phase 2b study of the experimental treatment CDX-011 ­— for patients with a certain type of advanced breast cancer — showed an overall survival benefit. Brean Capital called the results impressive, telling clients the drug “targets a clear and large unmet need.” Celldex’s chief medical officer said the company will have talks with the FDA this month on “a pivotal study” designed to pave the way for marketing approval.

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of